Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jul;83(3):279-84.
doi: 10.1007/s11060-006-9313-z. Epub 2007 May 26.

Pattern of recurrence in paediatric malignant glioma: an institutional experience

Affiliations

Pattern of recurrence in paediatric malignant glioma: an institutional experience

Sucheta J Vaidya et al. J Neurooncol. 2007 Jul.

Abstract

Background: The purpose of this retrospective study was to investigate the pattern of recurrence in paediatric malignant gliomas.

Material and methods: We reviewed the notes, diagnostic imaging and treatment charts of 30 consecutive paediatric patients (age less than 18 years at diagnosis, range 0.5-17 years) presenting with a malignant glioma presenting to the paediatric oncology unit at the Royal Marsden Hospital over a 10-year period. The imaging at the time of first relapse was compared with the initial diagnostic scans to define a relapse as local, marginal or distant.

Results: Median follow-up was 13 months (range 1-99 months). Twenty-four of 30 patients (80%) showed evidence of progression with a median time to progression of 8.5 months (range 3-64 months). Thirteen out of 24 patients developed local or marginal recurrences while 11/24 patients recurred at distant sites as site of first relapse (46%).

Conclusion: Our series suggests that the pattern of relapses in paediatric malignant gliomas could be different from that reported in adult studies as we observed a significant incidence of distant relapses. Larger prospective series need to be conducted to investigate the clinico-biological characteristics of the population at high risk for leptomeningeal dissemination.

PubMed Disclaimer

References

    1. Cancer Chemother Pharmacol. 1997;39(4):376-9 - PubMed
    1. J Neurooncol. 1994;21(3):255-65 - PubMed
    1. J Neurosurg. 1989 Jul;71(1):1-9 - PubMed
    1. J Neurooncol. 1998 May;38(1):83-9 - PubMed
    1. Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):677-80 - PubMed

LinkOut - more resources